Inhibidores
Los inhibidores son moléculas que se unen a enzimas, receptores u otras proteínas para reducir o bloquear su actividad biológica. Estos compuestos se utilizan ampliamente en la investigación para estudiar vías biológicas, comprender los mecanismos de las enfermedades y desarrollar fármacos terapéuticos. Los inhibidores desempeñan un papel crucial en el tratamiento de diversas enfermedades, incluyendo el cáncer, las enfermedades cardiovasculares y las infecciones. En CymitQuimica, ofrecemos una amplia gama de inhibidores de alta calidad para apoyar su investigación en bioquímica, biología celular y desarrollo farmacéutico.
Subcategorías de "Inhibidores"
- Angiogénesis(2.542 productos)
- Apoptosis(5.816 productos)
- Ciclo celular / Checkpoint(4.466 productos)
- Cromatina / Epigenética(2.252 productos)
- Señalización citoesquelética(1.381 productos)
- Daño al ADN / Reparación del ADN(2.830 productos)
- Endocrinología / Hormonas(3.518 productos)
- Enzima(3.640 productos)
- GPCR / proteína G(8.362 productos)
- Inmunología e inflamación(3.540 productos)
- Virus de la gripe(296 productos)
- Señalización JAK / STAT(405 productos)
- Señalización MAPK(1.201 productos)
- Transportador de membrana / canal de iones(2.809 productos)
- Metabolismo(9.462 productos)
- Microbiología / Virología(7.003 productos)
- Neurociencia(9.942 productos)
- Otros inhibidores(37.827 productos)
- Reducción de oxidación(40 productos)
- Señalización PI3K / Akt / mTOR(1.399 productos)
- Proteasas / Proteasoma(1.598 productos)
- Células madre y Derivados(830 productos)
- Tirosina quinasa / adaptadores(2.012 productos)
- Ubiquitinación(1.651 productos)
Mostrar 16 subcategorías más
Se han encontrado 66618 productos de "Inhibidores"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
HPK1-IN-30
CAS:<p>HPK1-IN-30 is a potent inhibitor of HPK1. HPK1-IN-30 has potential for cancer disease research.</p>Fórmula:C25H23FN6Forma y color:SolidPeso molecular:426.49NPEC-caged-(S)-3,4-DCPG
CAS:<p>mGlu8a agonist</p>Fórmula:C19H16N2O10Pureza:98%Forma y color:SolidPeso molecular:432.34RIPK1-IN-14
CAS:<p>RIPK1-IN-14 inhibits RIPK1 with 92 nM IC50 and reduces necrotic apoptosis in U937 cells.</p>Forma y color:SoildTTT 3002
CAS:<p>TTT 3002: oral FLT3 inhibitor for AML research, blocks D835 mutations, potent at 0.2 nM IC50.</p>Fórmula:C27H23N5O3Forma y color:SolidPeso molecular:465.50TRPV1 antagonist 3
<p>TRPV1 antagonist 3 (7q) strongly blocks TRPV1 at 2.66 nM IC50, is selective, 60% bioavailable, and crosses the blood-brain barrier.</p>Fórmula:C23H25N3OSForma y color:SolidPeso molecular:391.53Carbacyclin
CAS:<p>Carbacyclin, a PGI2 analog, is a prostacyclin (PGI2) receptor agonist and vasodilator with potent inhibitory platelet aggregation.</p>Fórmula:C21H34O4Pureza:98%Forma y color:SolidPeso molecular:350.49Estrogen receptor antagonist 6
CAS:<p>Estrogen receptor antagonist 6 is a potent blocker of estrogen signaling, regulating various biological effects. (Compound 166)</p>Fórmula:C25H31F3N2O3Forma y color:SolidPeso molecular:464.523'-Hydroxy Repaglinide
CAS:<p>'3'-Hydroxy Repaglinide, a CYP2C8 metabolite of Repaglinide, treats type II diabetes.</p>Fórmula:C27H36N2O5Pureza:98%Forma y color:SolidPeso molecular:468.59JAK3/BTK-IN-3
CAS:<p>JAK3/BTK-IN-3: strong dual JAK3/BTK suppressor, promising for autoimmune disease research.</p>Fórmula:C22H28N8OForma y color:SolidPeso molecular:420.51ZLM-66
<p>ZLM-66: Doravirine analog, HIV-1 NNRTI inhibitor, IC50: 41nM, EC50: HIV-1 13nM, cIAP1 0.32nM; useful in AIDS research.</p>Forma y color:SolidCap-dependent endonuclease-IN-2
<p>Cap-dependent endonuclease-IN-2 strongly blocks influenza A virus RNA polymerase; it's a CEN inhibitor.</p>Fórmula:C30H24FN3O7SForma y color:SolidPeso molecular:589.59L2H2-6OTD
CAS:<p>L2H2-6OTD is a telomerase inhibitor with G-quadruplex loops; IC50: 15 nM.</p>Fórmula:C30H30N10O8Forma y color:SolidPeso molecular:658.62Emd 52297
CAS:<p>Emd 52297 is an inhibitor of renin.</p>Fórmula:C39H59N11O7Pureza:98%Forma y color:SolidPeso molecular:793.96CCG258747
CAS:CCG258747 is a novel, selective inhibitor of the GRK2 subfamily.Fórmula:C28H27FN4O4Forma y color:SolidPeso molecular:502.54AZD4625
<p>AZD4625 (Compound 21) is a selective, potent, orally active, covalent and mutagenic mutant GTPaseKRASG12C inhibitor.</p>Fórmula:C24H21ClF2N4O3Forma y color:SolidPeso molecular:486.9D-473
CAS:<p>D-473 is a novel orally active triple reuptake inhibitor targeting dopamine, serotonin and norepinephrine transporters.</p>Fórmula:C26H27F2NO3Forma y color:SolidPeso molecular:439.49Adecypenol
CAS:<p>Adecypenol is a unique adenosine deaminase inhibitor. It shows effective inhibitory activity against calf intestinal adenosine deaminase.</p>Fórmula:C12H16N4O4Pureza:98%Forma y color:SolidPeso molecular:280.28Tubulin polymerization-IN-34
<p>"Tubulin-IN-34 inhibits oxazolylisoindole microtubule assembly, selective for VL51 lymphoma."</p>Fórmula:C31H35N3O6Forma y color:SolidPeso molecular:545.63GLPG0492 (R enantiomer)
CAS:GLPG0492 R enantiomer is the R enantiomer of GLPG-0492, a novel selective androgen receptor modulator.Fórmula:C19H14F3N3O3Forma y color:SolidPeso molecular:389.33SMP-797 HCl
CAS:<p>SMP-797 HCl, an ACAT (acyl-CoA-cholesterol acyltransferase) inhibitor, is used potentially for the treatment of Hyperlipidemia.</p>Fórmula:C34H44ClN5O4Pureza:98%Forma y color:SolidPeso molecular:622.20AMG-548 hydrochloride
<p>AMG-548 hydrochloride: orally active, p38α inhibitor (Ki=0.5 nM), 1000x less for p38γ/δ, also blocks TNFα (IC50=3 nM) & inhibits casein kinase 1 δ/ε.</p>Fórmula:C29H28ClN5OForma y color:SolidPeso molecular:498.02p38 MAPK-IN-3
<p>Compound 2c is a potent p38α MAPK inhibitor with antitumor effects, enhancing apoptosis and ROS.</p>Fórmula:C22H17BrO2Forma y color:SolidPeso molecular:393.27Purine phosphoribosyltransferase-IN-1
<p>Compound (S,R)-48 inhibits Pf, Pv, & Tbr PRT with Ki of 50, 20, 2 nM.</p>Fórmula:C11H15N5Na4O10P2Forma y color:SolidPeso molecular:531.17NR1H4 activator 1
CAS:NR1H4 activator 1 is a potent and selective agonist of Famesoid X Receptor (FXR).Fórmula:C34H53NO7SPureza:98%Forma y color:SolidPeso molecular:619.85BTK-IN-7
<p>BTK-IN-7 is a potent inhibitor for BTK with 4.0 nM IC50, highly selective over ITK and EGFR, showing strong antitumor activity.</p>Fórmula:C30H32N6O4Forma y color:SolidPeso molecular:540.61(±)-HIP-B
CAS:<p>(±)-HIP-B is an excitatory amino acid transporter blocker.</p>Fórmula:C6H8N2O4Pureza:98%Forma y color:SolidPeso molecular:172.14ADP-2341
<p>ADP-2341 is a soluble analog of FiVe1.</p>Fórmula:C24H29Cl2N5O3Forma y color:SolidPeso molecular:506.43Human carbonic anhydrase II-IN-2
<p>Compound R-13, a potent inhibitor of hCA I/II/IV/IX with K i s of 60.7, 320.7, 2298, and 35.2 nM.</p>Fórmula:C20H25N3O4SForma y color:SolidPeso molecular:403.5Cdc7-IN-11
CAS:<p>Cdc7-IN-11 is a potent inhibitor of Cdc7 (IC50 ≤ 1 nM) and can be used in the study of proliferative diseases.</p>Fórmula:C20H22F2N4O2SForma y color:SolidPeso molecular:420.48Calcipotriol Impurity C
CAS:<p>Calcipotriol Impurity C is the impurity of Calcipotriol. Calcipotriol is a VDR-like receptors ligand.</p>Fórmula:C27H40O3Pureza:98%Forma y color:SolidPeso molecular:412.614DHFR-IN-4
CAS:<p>DHFR-IN-4 is a potent dihydrofolate reductase (DHFR) inhibitor with anti-tumour activity, inhibits EGFR and HER2 and can be used to study pancreatic cancer.</p>Fórmula:C18H21N5O2SPureza:99.41%Forma y color:SolidPeso molecular:371.46Ganciclovir monophosphonate
CAS:<p>Ganciclovir monophosphate treats CMV, inhibiting replication in human/animal strains (IC50: 0.01μM).</p>Fórmula:C10H16N5O6PForma y color:SolidPeso molecular:333.24CHK1 inhibitor
CAS:CHK1 inhibitor (GDC-0575 analog) is a CHK1 inhibitor.Fórmula:C17H21BrN4OPureza:98%Forma y color:SolidPeso molecular:377.28TX2-121-1
CAS:<p>TX2-121-1 targets HER3 for proteasome-mediated degradation to inhibit HER3-dependent signalling and growth.</p>Fórmula:C42H52N8O3Pureza:98%Forma y color:SolidPeso molecular:716.91SC-435 mesylate
CAS:<p>SC-435 is an ileal apical sodium co-dependent bile acid transporter (ASBT). SC-435 inhibits plasma cholesterol.</p>Fórmula:C37H59N3O7S2Pureza:98%Forma y color:SolidPeso molecular:722.01LEO 134310
CAS:<p>LEO 134310: Selective, non-steroidal GR agonist with 14 nM EC50, for topical skin disease treatment.</p>Fórmula:C34H40N2O8Forma y color:SolidPeso molecular:604.69PF-06795071
CAS:<p>PF-06795071 is an effective and selective covalent inhibitor of MAGL (IC50: 3 nM).</p>Fórmula:C18H17F4N3O3Pureza:98%Forma y color:SolidPeso molecular:399.34SIK1 activator 1
CAS:<p>SIK1 activator 1 boosts SIK1 phosphorylation, reduces type 2 diabetes hyperglycemia, and inhibits liver gluconeogenesis.</p>Fórmula:C23H32O6Forma y color:SolidPeso molecular:404.50RAD51-IN-5
CAS:<p>RAD51-IN-5 blocks RAD51; may aid mitochondrial disorder research. (WO2021164746A1, cmpd 3)</p>Fórmula:C26H38N4O5S2Forma y color:SolidPeso molecular:550.73Topoisomerase II inhibitor 5
<p>Topoisomerase II inhibitor 5 (Compound E24) is a DNAtopoisomerase II inhibitor with anticancer effects.</p>Fórmula:C26H27N5O4Forma y color:SolidPeso molecular:473.52β-Glucuronidase-IN-2
<p>β-Glucuronidase-IN-2 is a potent inhibitor of E.</p>Fórmula:C21H17Cl3O7Forma y color:SolidPeso molecular:487.71Revexepride
CAS:<p>Revexepride, a 5-HT4 agonist, may boost CYP3A4, used for treating GERD.</p>Fórmula:C21H32ClN3O4Pureza:98%Forma y color:SolidPeso molecular:425.95Tubulin inhibitor 16
<p>Tubulin inhibitor 16 is a potent tubulin inhibitor with antiproliferative activity. Tubulin inhibitor 16 exhibits cytotoxicity in HepG2 cells [1].</p>Fórmula:C16H12FNO2Forma y color:SolidPeso molecular:269.27Purine phosphoribosyltransferase-IN-2
<p>Purine PRTase-IN-2 inhibits Pf, Pv, Tbr PRT; Ki: 30, 20, 2 nM.</p>Fórmula:C11H15N5Na4O10P2Forma y color:SolidPeso molecular:531.17KRAS G12D inhibitor 11
CAS:<p>KRAS G12D inhibitor 11 targets KRAS G12D in cancer research (patent WO2021108683A1, compound 52).</p>Fórmula:C29H38BN5O3Forma y color:SolidPeso molecular:515.45GDC-6036-NH
CAS:<p>GDC-6036-NH is a precursor of compound 17a /b, which is a RAS inhibitor that can be used in cancer research.</p>Fórmula:C26H30ClF4N7OPureza:99.84%Forma y color:SolidPeso molecular:568.01Antifungal agent 12
<p>Antifungal agent 12 is a new fluconazole-like compound that exhibits good antifungal effects.</p>Fórmula:C20H16F3N7O2S2Forma y color:SolidPeso molecular:507.51FXIa-IN-6
CAS:<p>FXIa-IN-6: Potent, selective FXIa inhibitor (Ki=0.3 nM); strong PK with high oral bioavailability, low clearance preclinically.</p>Fórmula:C31H29ClF2N4O4Forma y color:SolidPeso molecular:595.04Trilobolide
CAS:<p>Trilobolide is a natural counterpart of thapsigargin and an activator of cytokine secretion.</p>Fórmula:C27H38O10Forma y color:SolidPeso molecular:522.58LpxA-IN-1
CAS:<p>LpxA-IN-1, a novel UDP-N-acetylglucosamine acyltransferase (LpxA) inhibitor exhibiting potent activity (IC 50 2 nM), effectively targets Pseudomonas aeruginosa</p>Fórmula:C21H11D7F3N5O3Forma y color:SolidPeso molecular:452.44Anticancer agent 44
<p>Anticancer agent 44 induces apoptosis, is selective, cytotoxic to cancer cells, and minimally toxic to human lymphocytes.</p>Fórmula:C22H13Cl2N3O5S2Forma y color:SolidPeso molecular:534.39Cryptopleurine
CAS:<p>Cryptopleurine is an inhibitor of gene products associated with cell proliferation, survival, invasion and angiogenesis. It acts by targeting the NF-κB pathway.</p>Fórmula:C24H27NO3Pureza:98%Forma y color:SolidPeso molecular:377.48ML-SI1
CAS:<p>ML-SI1, a racemic mixture of diastereoisomers, is a TRPML inhibitor and acts on TRPML1 (IC50: 15 μM).</p>Fórmula:C23H26Cl2N2O3Forma y color:SolidPeso molecular:449.37NA 0362
CAS:<p>NA 0362 is a derivative of SF 2370 that inhibits smooth muscle contraction.</p>Fórmula:C28H26N4O4Forma y color:SolidPeso molecular:482.53PGDM
CAS:<p>PGD2 is involved in allergy, asthma, sleep, temperature regulation, inhibits clotting, and relaxes blood vessels; PGDM, its metabolite, is a biomarker.</p>Fórmula:C16H24O7Forma y color:SolidPeso molecular:328.36TCMDC-125431
<p>TCMDC-125431 is a novel inhibitor of Plasmodium calcium kinetics with minimal inhibition of haemoglobin crystals.</p>Fórmula:C25H27N3O2SForma y color:SolidPeso molecular:433.57LSD1-IN-19
<p>LSD1-IN-19 is a potent, selective LSD1 inhibitor with Ki of 0.108 μM and 72h IC50 values of 0.17-0.40 μM.</p>Fórmula:C33H42N6O2Forma y color:SolidPeso molecular:554.73Topoisomerase IIα-IN-4
<p>Topoisomerase IIα-IN-4 (F2) is a non-intercalative ATP-competitive inhibitor of human DNA topoisomerase II, specifically inhibiting TopoIIα with an IC50 value</p>Fórmula:C25H21NO2Forma y color:SolidPeso molecular:367.44Antiviral agent 7
<p>Antiviral agent 7 is a peptide-based coating that kills viruses.</p>Fórmula:C29H31F2N3O6Forma y color:SolidPeso molecular:555.57CP-608039
CAS:<p>CP-608039 is a selective adenosine A3 receptor agonist for both human A3 and human A1 receptors.</p>Fórmula:C23H25ClN8O5Forma y color:SolidPeso molecular:528.95[D-Leu-4]-OB3
CAS:[D-Leu-4]-OB3 suppresses the expression of genes associated with inflammation, proliferation, and metastasis, as well as the expression of PD-L1.Fórmula:C29H50N8O12SForma y color:SolidPeso molecular:734.82Salvinorin A Propionate
CAS:<p>Salvinorin A propionate: partial KOR agonist, Ki=32.6 nM, EC50=4.7 nM; ignores μ/δ/ORL-1, non-opioid receptors; less potent analgesic vs. salvinorin A.</p>Fórmula:C24H30O8Forma y color:SolidPeso molecular:446.49Aurora A inhibitor 1
CAS:<p>Aurora A inhibitor 1: potent, selective, targets cancer-linked Aurora A overexpression, potential for cancer research. (WO2021147974A1, 49)</p>Fórmula:C25H28ClF2N5O2Forma y color:SolidPeso molecular:503.97RXR antagonist 1
<p>RXR antagonist 1 is a Retinoid X Receptor (RXR) modulator that exhibits high RXR antagonism (pA2: 8.06). RXR antagonist 1 can be used to study type 2 diabetes.</p>Fórmula:C28H33F3N2O3Forma y color:SolidPeso molecular:502.57β-Glucuronidase/hCAII-IN-2
<p>β-Glucuronidase/hCAII-IN-2 is a potent inhibitor of β-glucuronidase and hCA II, and their IC50 values were 670.7 μM and 21.77 μM, respectively.</p>Fórmula:C31H23NO8Forma y color:SolidPeso molecular:537.52MF-592
CAS:<p>MF-592: EP4 receptor antagonist, hEP4 IC50 3 nM, hWB IC50 78 nM, great oral PK, rat arthritis ED50 0.1 mg/kg/day, promising for development.</p>Fórmula:C34H33Cl2N3O6SForma y color:SolidPeso molecular:682.61Kahweol linoleate
CAS:<p>Kahweol linoleate, a semi-synthetic from coffee, blocks osteoclast creation, fights cancerous cells, prevents DNA damage, and reduces oxidative stress.</p>Fórmula:C38H56O4Forma y color:SolidPeso molecular:576.85CYP2C1/CYP2C19-IN-2
<p>CYP2C1/CYP2C19-IN-2 is a potent inhibitor of CYP2C9/CYP2C19 without liver toxicity or genotoxicity and can be used to study Zika virus (ZIKV) infection.</p>Fórmula:C27H28N2O6SForma y color:SolidPeso molecular:508.59RSK4-IN-1
CAS:<p>RSK4-IN-1 is a compound exhibiting potent inhibition of RSK4, demonstrated by an IC50 value of 9.5 nM.</p>Fórmula:C19H20F2N4O3Forma y color:SolidPeso molecular:390.38PIKfyve-IN-1
<p>PIKfyve-IN-1: potent, cell-active inhibitor for PIKfyve research, IC50=6.9 nM.</p>Fórmula:C20H21N5Forma y color:SolidPeso molecular:331.41DS96432529
<p>DS96432529 is a potent and orally active bone anabolic agent through CDK8 inhibition.</p>Fórmula:C18H26N4O3SForma y color:SoildPeso molecular:378.49JBIR-22
CAS:<p>JBIR-22 is a natural inhibitor for protein−protein interaction of the homodimer of proteasome assembly factor 3.</p>Fórmula:C23H33NO6Forma y color:SolidPeso molecular:419.51MB725
CAS:<p>MB725 is a strong and selective inducer of viability reduction in several cancer cell lines containing the oncogenic p53-Y220C mutation.</p>Fórmula:C18H21IN4O2SForma y color:SolidPeso molecular:484.35ROPA
CAS:<p>ROPA, a potent PKCalpha and PKCgamma activator, promotes tumor growth through PKC-activation.</p>Fórmula:C28H32O6Pureza:98%Forma y color:SolidPeso molecular:464.55PD 140376
CAS:<p>PD 140376: Selective CCK-B/gastrin receptor antagonist radioligand for guinea pig stomach & brain.</p>Fórmula:C33H40N4O5Pureza:98%Forma y color:SolidPeso molecular:572.69Motuporin
CAS:<p>Motuporin is an inhibitor of type-1 and type-2A protein phosphatase catalytic subunits (PP-1c and PP-2Ac).</p>Fórmula:C40H57N5O10Forma y color:SolidPeso molecular:767.91NK1 receptor antagonist 2
CAS:<p>NK1 Receptor Antagonist 2, a compound targeting the NK1 receptor, holds potential for tinnitus and hearing loss research.</p>Fórmula:C31H35F7N4O2Forma y color:SolidPeso molecular:628.62Uprosertib hydrochloride
CAS:<p>Uprosertib hydrochloride is a potent and selective inhibitor of pan-Akt (IC50: 180/328/38 nM for Akt1/Akt2/Akt3, respectively).</p>Fórmula:C18H17Cl3F2N4O2Pureza:98%Forma y color:SolidPeso molecular:465.71AChE/BChE-IN-3 hydrochloride
<p>AChE/BChE-IN-3 (BMC-1) HCl is a dual inhibitor with IC50s: eqBChE 0.383 μM, elAChE 6.08 μM.</p>Fórmula:C15H25ClN2O3Forma y color:SolidPeso molecular:316.82PF-4693627
CAS:<p>PF-4693627 is an effective and selective microsomal prostaglandin E synthase-1 inhibitor (IC50=3 nM).</p>Fórmula:C26H29Cl2N3O3Pureza:98%Forma y color:SolidPeso molecular:502.43NS2B/NS3-IN-3
CAS:<p>NS2B/NS3-IN-3 (Compd 66) is an inhibitor of Flavivirus NS2B-NS3 protease [1] .</p>Fórmula:C19H21N3O2Forma y color:SolidPeso molecular:323.39NB-533
CAS:<p>NB-533 is a macrocyclic peptidic BACE-1 inhibitor.</p>Fórmula:C33H55N3O4Forma y color:SolidPeso molecular:557.81CP-481715
CAS:<p>CP 481715 is an effective selective CCR1 antagonist with potential therapeutic significance for inflammatory diseases.</p>Fórmula:C26H31FN4O4Forma y color:SolidPeso molecular:482.55Pyridoxatin
CAS:<p>Pyridoxatin: fungal metabolite; blocks TBARS production, prevents AAPH-induced hemolysis, and acts against C. albicans.</p>Fórmula:C15H21NO3Forma y color:SolidPeso molecular:263.33CRM1 degrader 1
<p>CRM1 degrader 1 (1l) is a low-toxic CRM1 degrader that induces apoptosis in gastric carcinoma and selectively inhibits the proliferation of gastric cancer[1].</p>Fórmula:C16H20O3Forma y color:SolidPeso molecular:260.33DC41
CAS:<p>DC41 is a CC-1065-based cancer drug, an antibody-linked DNA alkylator.</p>Fórmula:C37H34ClN5O4SPureza:98%Forma y color:SolidPeso molecular:680.22Tubulin polymerization-IN-3
<p>Tubulin polymerization-IN-3 is a potent inhibitor of microtubulin polymerization (IC50: 3.84 μM) and induces apoptosis in colon cancer cells.</p>Fórmula:C20H20ClN5O3Forma y color:SolidPeso molecular:413.86ACT-777991
CAS:<p>ACT-777991: oral CXCR3 blocker, stable in microsomes/hepatocytes, inhibits T-cell migration to CXCL11.</p>Fórmula:C20H20F6N8O2SForma y color:SolidPeso molecular:550.48FT3967385
<p>FT3967385: New USP30 inhibitor boosts mitochondrial ubiquitylation via PINK1-PARKIN.</p>Fórmula:C21H19N5O2Forma y color:SolidPeso molecular:373.41CS-0777
CAS:<p>CS-0777 is a potent, selective, and orally active S1P1 agonist (sphingosine 1-phosphate receptor modulator).</p>Fórmula:C21H31N2O5PForma y color:SolidPeso molecular:422.45Azonafide-PEABA
CAS:<p>Azonafide-PEABA is a drug moiety with cytotoxic [1].</p>Fórmula:C32H33N5O4Pureza:98%Forma y color:SolidPeso molecular:551.64SARS-CoV-2-IN-24
<p>SARS-CoV-2-IN-24 blocks PLpro, altering its shape and stopping virus replication—useful for SARS-CoV-2 research.</p>Fórmula:C27H30N4O5Forma y color:SolidPeso molecular:490.55GT-055
<p>GT-055 (LCB18-055) is a novel inhibitor of broad-spectrum β-lactamase.</p>Fórmula:C13H20F3N5O8SForma y color:SolidPeso molecular:463.39AL-6556
CAS:<p>AL-6556 is a prostaglandin DP receptor agonist.</p>Fórmula:C20H33ClO5Forma y color:SolidPeso molecular:388.93NS2B/NS3-IN-5
<p>Compound 25b inhibits DENV2/ZIKV NS2B/NS3 proteases; IC50: ZIKV 0.67μM, DENV2 4.38μM.</p>Fórmula:C14H9IN2O3SForma y color:SolidPeso molecular:412.2BAY-7598
CAS:<p>BAY-7598 is a potent, selective, and orally bioavailable MMP12 inhibitor (IC50s: 0.085, 0.67, and 1.1 nM for human/murine/rat MMP12).</p>Fórmula:C28H31N3O6Pureza:98%Forma y color:SolidPeso molecular:505.56BRD2879
CAS:<p>BRD2879 is a potent and cell-active inhibitor of IDH1-R132H (IC50 = 50 nM).</p>Fórmula:C30H38FN3O5SPureza:98%Forma y color:SolidPeso molecular:571.70Bcl-2-IN-7
<p>Bcl-2-IN-7 inhibits Bcl-2, encourages apoptosis in cancer cells, and has anti-tumor activity with various IC50 values.</p>Fórmula:C24H22N4O5S2Forma y color:SolidPeso molecular:510.59Tuberculosis inhibitor 5
<p>Compound 11i: potent, non-toxic anti-tuberculosis biphenyl analogue.</p>Fórmula:C25H18N2O2SForma y color:SolidPeso molecular:410.49Leualacin
CAS:<p>Leualacin is a novel calcium blocker from Hapsidospora irregularis.</p>Fórmula:C31H47N3O7Pureza:98%Forma y color:SolidPeso molecular:573.72AS1940477
CAS:<p>AS1940477 selectively inhibits p38 MAPK α/β, blocks proinflammatory cytokines in cells, and has anti-inflammatory effects in rats.</p>Fórmula:C24H22FN5O2Forma y color:SolidPeso molecular:431.46Trk-IN-7
<p>Trk-IN-7 inhibits TRKA/B/C (IC50: 0.25-10 nM) & EML4-ALK (<15 nM), also targets various ALK mutations (IC50: 5-50 nM).</p>Fórmula:C18H17FN6O2Forma y color:SolidPeso molecular:368.36Latrunculins A
CAS:Latrunculins A is a novel marine toxin, disrupts microfilament organization in cultured cells.Fórmula:C22H31NO6SForma y color:SolidPeso molecular:437.55PDE-I2
CAS:<p>PDE-I2 is a parasite schizogony inhibitor.</p>Fórmula:C25H23N5O8Forma y color:SolidPeso molecular:521.48Ambrosin
CAS:<p>Ambrosin is a sesquiterpene lactone and a potent NF-κβ inhibitor. It is currently being studied as a potential lead drug for Alzheimer disease therapeutics.</p>Fórmula:C15H18O3Forma y color:SolidPeso molecular:246.3Olanzapine/Samidorphan
CAS:<p>Olanzapine/Samidorphan, a tablet blending olanzapine and samidorphan, targets schizophrenia and bipolar I, curbing weight gain.</p>Fórmula:C38H46N6O4SForma y color:SolidPeso molecular:682.88Antitumor agent-50
<p>Antitumor agent-50 (compound 1a) is a thiazolidinone.</p>Fórmula:C17H14FNO3SForma y color:SolidPeso molecular:331.36hA3AR agonist 1
<p>hA3AR agonist 1 is a potent human A 3 adenosine receptor (hA 3 AR) agonist (Ki = 2.40 nM) .</p>Fórmula:C10H14N6OSForma y color:SolidPeso molecular:266.32HDAC6-IN-9
CAS:<p>HDAC6-IN-9 is a γ-secretase modulator that can significantly reduce the level of Aβ42 in mouse brain and can be used to study neurological diseases.</p>Fórmula:C19H16N2O3Pureza:98.84%Forma y color:SolidPeso molecular:320.34Antibacterial agent 75
<p>Antibacterial agent 75 re-sensitizes VRSA to vancomycin.</p>Fórmula:C22H28N6OForma y color:SolidPeso molecular:392.5GPR81 agonist 2
CAS:<p>GPR81 agonist 2 is a potent agonist targeting the GPR81 receptor, demonstrating EC50 values of 0.023 µM for hGPR81 and 0.123 µM for hGPR109A, respectively.</p>Fórmula:C26H27ClN6O5S2Forma y color:SolidPeso molecular:603.11XP-524
CAS:<p>XP-524: BET & EP300 inhibitor, suppresses KRAS tumors in vivo, targets PDAC, boosts immune response.</p>Fórmula:C30H28N6O3SForma y color:SolidPeso molecular:552.65Rosiptor acetate
CAS:<p>Rosiptor (AQX-1125) activates SHIP1, inhibits Akt, and reduces inflammation and allergy in rodents.</p>Fórmula:C22H39NO4Pureza:98%Forma y color:Solid PowderPeso molecular:381.55L 668750
CAS:<p>L 668750 is an inhibitor of platelet-activating factor.</p>Fórmula:C25H34O9SPureza:98%Forma y color:SolidPeso molecular:510.6CE-2072
CAS:<p>CE-2072 is a synthetic host serine proteases inhibitor.</p>Fórmula:C33H41N5O6Pureza:98%Forma y color:SolidPeso molecular:603.71SLN124
<p>SLN124, a GalNAc-siRNA targeting TMPRSS6, may normalize iron balance by restoring ferroregulation.</p>Forma y color:SolidMAO A/HDAC-IN-1
<p>MAO A/HDAC-IN-1 is an effective monoamine oxidase A (MAO A) and HDAC dual inhibitor, which can be used for glioma research.</p>Fórmula:C21H24ClN3O3Forma y color:SolidPeso molecular:401.89AMD-7049
CAS:<p>AMD-7049 is a biochemical.</p>Fórmula:C25H39N5Forma y color:SolidPeso molecular:409.61trans-Doxercalciferol
CAS:<p>trans-Doxercalciferol is an isomer of Doxercalciferol. Doxercalciferol is an activator of the Vitamin D receptor and prevents renal disease.</p>Fórmula:C28H44O2Pureza:98%Forma y color:SolidPeso molecular:412.65YEATS4 binder-1
<p>YEATS4 binder-1(4e) is an effective and selective compound that targets the KAc recognition site within the YEATS structural domain, exhibiting a binding</p>Fórmula:C23H34N4O3Forma y color:SolidPeso molecular:414.54IAA65
CAS:<p>IAA65 is a potent inhibitor of T-type calcium channels, exhibiting an IC50 value of 18.9 μM, and holds potential for use in epilepsy research [1].</p>Fórmula:C16H13F6NO2Forma y color:SolidPeso molecular:365.27Rimegepant sulfate hydrate
CAS:<p>Rimegepant (BMS-927711/BHV-3000): oral CGRP blocker for migraines, effective without vasoconstriction, beats placebo, well-tolerated.</p>Fórmula:C56H64F4N12O13SForma y color:SolidPeso molecular:1221.2526HBV-IN-11
CAS:<p>HBV-IN-11 is a potent inhibitor of HBsAg secretion (EC50: 0.46 μM).</p>Fórmula:C21H24ClNO6Forma y color:SolidPeso molecular:421.87SHR2415
<p>SHR2415: Potent, selective ERK1/2 inhibitor, oral; ERK1 IC50: 2.8 nM, ERK2 IC50: 5.9 nM; effective in Colo205 (IC50: 44.6 nM), for cancer research.</p>Fórmula:C23H22ClN7O2Forma y color:SolidPeso molecular:463.92CM-414
CAS:<p>CM-414: HDAC/PDE5 inhibitor, targeting Alzheimer’s, IC50s: PDE5 (60 nM), HDAC1/2/3/6. Reduces Aβ, pTau in mice, boosts cognition.</p>Fórmula:C23H29N5O4Pureza:98%Forma y color:SolidPeso molecular:439.51DNA gyrase B-IN-1
<p>DNA gyrase B-IN-1, a potent inhibitor of P. aeruginosa DNA gyrase B, has IC50 of 2.2 μM with high affinity and stability.</p>Fórmula:C23H18ClF3N6O4SForma y color:SolidPeso molecular:566.94J-104132
CAS:<p>J-104132: potent human ETA/B antagonist; Ki: ETA=0.034nM, ETB=0.104nM; prevents ET-1 effects, ED50 i.v.=0.045mg/kg, p.o.=0.35mg/kg.</p>Fórmula:C31H33NO7Pureza:98%Forma y color:SolidPeso molecular:531.60AZ0108
CAS:<p>AZ0108, an oral PARP1,2,6 inhibitor, selectively blocks centrosome clustering, is viable for in vivo studies, and doesn't inhibit PARP3/TNKS1.</p>Fórmula:C24H20F4N6O2Forma y color:SolidPeso molecular:500.45SR121566A
CAS:SR121566A is a novel non-peptide antagonist of Glycoprotein IIb/IIIa (GP IIb-IIIa).Fórmula:C20H25N5O4SPureza:98%Forma y color:SolidPeso molecular:431.51Exicorilant
CAS:<p>Exicorilant is a selective oral GR antagonist (Ki: 7 nM) that may reduce obesity, glucose intolerance, & dyslipidemia.</p>Fórmula:C26H23F4N7O3SPureza:98%Forma y color:SolidPeso molecular:589.56DS89002333
<p>DS89002333: oral PRKACA inhibitor with 0.3 nM IC50, effective against FL-HCC with DNAJB1-PRKACA fusion in xenografts.</p>Fórmula:C22H20ClF2N3O3Forma y color:SolidPeso molecular:447.86CDK5-IN-2
CAS:<p>CDK5-IN-2 (compound 15) is a highly selective CDK5 inhibitor that acts on CDK5/p25 (IC50: 0.2 nM) and CDK2/CycA (IC50: 23 nM).</p>Fórmula:C29H28FN5OForma y color:SolidPeso molecular:481.56PD-1-IN-17 TFA
<p>PD-1-IN-17 TFA is a potent PD-1 inhibitor, blocking 92% of splenocyte growth at 100 nM.</p>Fórmula:C15H23F3N6O9Forma y color:SolidPeso molecular:488.37AFP-07 free acid
CAS:<p>AFP 07 free acid is a 7,7-difluoroprostacyclin derivative. It also acts as a selective and highly potent agonist for the IP receptor.</p>Fórmula:C22H30F2O5Pureza:98%Forma y color:SolidPeso molecular:412.47γ-secretase modulator 5
<p>Compound 22d is a GSM that crosses the blood-brain barrier, inhibits Aβ42 production (IC50: 60 nM), and may help study Alzheimer's.</p>Forma y color:SolidSpliceostatin A
CAS:<p>Spliceostatin A is an anticancer agent and splicing inhibitor that induces apoptosis by inducing cell cycle arrest in the G1 and G2/M phases.</p>Fórmula:C28H43NO8Pureza:94.66%Forma y color:SolidPeso molecular:521.643ORIC-101
CAS:<p>ORIC-101 is a highly effective and selective glucocorticoid receptor antagonist (EC50: 5.6 nM). It also has anti-cancer activity.</p>Fórmula:C34H47NO2Pureza:98%Forma y color:SolidPeso molecular:501.748(S),15(S)-DiHETE
CAS:<p>8(S),15(S)-DiHETE, from 15(S)-HETE's oxidation by 15-LO, triggers eosinophil movement at 1.5 μM; it counteracts pain and LTB4 effects.</p>Fórmula:C20H32O4Forma y color:SolidPeso molecular:336.47STING agonist-7
<p>STING agonist-7 is an agonist of non-nucleotide STING that binds selectively to mouse STING but not human STING [1].</p>Fórmula:C17H12N4O4Forma y color:SolidPeso molecular:336.3Nolpitantium Free Base
CAS:<p>Nolpitantium is a potent, selective NK1 receptor antagonist that inhibits substance P without affecting NK2/NK3 receptors.</p>Fórmula:C37H45Cl2N2O2Forma y color:SolidPeso molecular:620.67SLC4101431
<p>SLC4101431 is a potent SphK2 inhibitor with Ki value of 90 nM.</p>Fórmula:C29H28ClN7OSForma y color:SolidPeso molecular:558.1MAO-B-IN-6
<p>MAO-B-IN-6 is a selective, potent, orally active MAO-B inhibitor (IC50: 0.019 μM). MAO-B-IN-6 is superior to Safinamide both in vitro and in vivo.</p>Forma y color:SolidRaloxifene N-Oxide
CAS:<p>Raloxifene N-Oxide is a Raloxifene oxidative degradation product.</p>Fórmula:C28H27NO5SPureza:98%Forma y color:SolidPeso molecular:489.58CLK1/2-IN-1
CAS:<p>CLK1/2-IN-1 is a CLK1 and CLK2 inhibitor and it also inhibits SRPK1 and SRPK2.</p>Fórmula:C21H20F3N7OPureza:98%Forma y color:SolidPeso molecular:443.42BMS-986163
CAS:<p>BMS-986163, a prodrug, quickly becomes BMS-986169, a GluN2B inhibitor (Ki=4 nM, IC50=24 nM).</p>Fórmula:C23H28FN2O5PPureza:98%Forma y color:SolidPeso molecular:462.45AX15910
<p>AX15910 is a potent inhibitor of BRD4 and ERK5.</p>Fórmula:C32H38N6O3Forma y color:SolidPeso molecular:554.7ACT-281959
CAS:<p>ACT-281959, a prodrug of ACT-246475, is a potent P2Y12 antagonist, better than Clopidogrel, effective orally, and in human trials.</p>Fórmula:C38H55N6O14PForma y color:SolidPeso molecular:850.85GSK3368715
CAS:<p>GSK3368715 is an orally active, reversible, and S-adenosyl-L-methionine (SAM) uncompetitive type I protein arginine methyltransferases (PRMTs) inhibitor (IC50s</p>Fórmula:C20H38N4O2Pureza:98%Forma y color:SolidPeso molecular:366.54Aniline-MPB-amino-C3-PBD
CAS:<p>Aniline-MPB-amino-C3-PBD is a cytotoxic agent comprised of the non-alkylating group. It is a sequence-selective DNA minor-groove binding agent.</p>Fórmula:C42H46N8O6Pureza:98%Forma y color:SolidPeso molecular:758.86G-744
CAS:<p>G-744 is a selective and orally active inhibitor of Btk (IC50: 2 nM).</p>Fórmula:C29H29N5O3SPureza:98%Forma y color:SolidPeso molecular:527.64Tezosentan
CAS:<p>Tezosentan is an antagonist of the endothelin receptor (pA2s: 9.5, 7.7 for ETA and ETB receptors, respectively).</p>Fórmula:C27H27N9O6SPureza:98%Forma y color:SolidPeso molecular:605.63ZK168281
CAS:<p>ZK168281 is a 1α,25(OH)2D3 analog, VDR antagonist with 0.1 nM Kd, and blocks receptor CoA interaction.</p>Fórmula:C32H46O5Pureza:98%Forma y color:SolidPeso molecular:510.70AChE-IN-24
<p>AChE-IN-24: Strong AChE blocker, crosses blood-brain barrier, IC50=0.053 μM, useful for AD research.</p>Fórmula:C22H30N2O4S2Forma y color:SolidPeso molecular:450.61Pol I-IN-1
<p>Pol I-IN-1 is a powerful inhibitor of RNA polymerase I (Pol I), specifically targeting the large catalytic subunit RPA194, demonstrating an inhibition</p>Fórmula:C23H22N4O2Forma y color:SolidPeso molecular:386.45FTI 276 TFA
CAS:FTI 276 TFA targets plasmodium falciparum & humans, inhibits PFT with IC50s: 0.9 nM (parasite) & 0.5 nM (human).Fórmula:C23H28F3N3O5S2Forma y color:SolidPeso molecular:547.61Heme Oxygenase-1-IN-2
<p>Heme Oxygenase-1-IN-2 is a novel inhibitor of heme oxygenase-1 (HO-1), displaying potent antiproliferative activity in vitro, with an IC50 value of 0.95 μM.</p>Fórmula:C19H18ClN3OForma y color:SolidPeso molecular:339.82GSK1820795A
CAS:<p>GSK1820795A: Telmisartan analog, selective hGPR132a antagonist, blocks yeast activation by N-acylamides, angiotensin II antagonist, partial PPARγ agonist.</p>Fórmula:C35H34N8Forma y color:SolidPeso molecular:566.7Ro 24-4383
CAS:<p>Ro 24-4383 is a carbamate-linked dual-action antibacterial agent.</p>Fórmula:C32H31FN8O10S2Pureza:98%Forma y color:SolidPeso molecular:770.76K203
<p>K203 is a potent tabun-inhibited AChE reactivator and is an important antidote to organophosphorus poisoning.</p>Fórmula:C16H18Br2N4O2Forma y color:SolidPeso molecular:458.15Mu opioid receptor antagonist 3
<p>Potent, selective MOR antagonist (compound 26); crosses blood-brain barrier. Ki: 0.24 nM, EC50: 0.54 nM; for studying OUD.</p>Fórmula:C25H28N2O4SForma y color:SolidPeso molecular:452.57Dyrk1A/α-synuclein-IN-1
<p>Dyrk1A/α-synuclein-IN-1 (Compound b1) is a dual inhibitor of Dyrk1A (IC50: 177 nM) and α-synuclein aggregation (IC50: 10.5 μM).</p>Fórmula:C20H21N5O3SForma y color:SolidPeso molecular:411.48Calpain Inhibitor-2
CAS:<p>Calpain Inhibitor-2: Lipophilic, moderates growth of A-375, B-16F1, PC-3 cancers, and hinders 80% DU-145 cell invasion.</p>Fórmula:C26H33N3O5SForma y color:SolidPeso molecular:499.62TRPA1 Antagonist 1
CAS:<p>TRPA1 Antagonist 1 is an antagonist of TRPA1(IC50: 8 nM) and is a methylene phosphate prodrug which converts to its active parent drug.</p>Fórmula:C24H20F6N5Na2O7PSPureza:98%Forma y color:SolidPeso molecular:713.45PDE1-IN-4
<p>PDE1-IN-4: inhibits PDE1C/A/B with IC50s 10/145/354 nM, may help study idiopathic pulmonary fibrosis.</p>Fórmula:C33H33N3O4Forma y color:SolidPeso molecular:535.63ATR-IN-17
CAS:<p>ATR-IN-17 is a potent inhibitor of ATR kinase with good anti-cancer effects in LoVo cells (IC50: 1 nM).</p>Fórmula:C22H28N6O2SForma y color:SolidPeso molecular:440.56Anti-inflammatory agent 18
<p>Anti-inflammatory agent 18: NO activity blocker (IC50: 15.94 μM), hampers HMGB1-induced inflammation, potential for COVID-19, sepsis study.</p>Fórmula:C30H50O6Forma y color:SolidPeso molecular:506.71Sulprostone
CAS:<p>EP3 and EP1 receptor agonist</p>Fórmula:C23H31NO7SPureza:98%Forma y color:White To Off-White SolidPeso molecular:465.56CARM1-IN-3 dihydrochloride
<p>CARM1-IN-3 dihydrochloride (17b) is a potent CARM1 inhibitor (IC50: 0.07 μM) with selectivity over CARM3 (IC50 >25 μM).</p>Fórmula:C24H34Cl2N4O2Forma y color:SolidPeso molecular:481.46CDK4/6-IN-3
CAS:<p>CDK4/6-IN-3 is a brain-penetrant CDK4/CDK6 inhibitor (Kis: <0.3 nM and 2.2 nM) used for the treatment of glioblastoma. It inhibits CDK1 with a Ki of 110 nM.</p>Fórmula:C25H31FN8Pureza:98%Forma y color:SolidPeso molecular:462.57MC2652
<p>MC2652, a potent LSD1 inhibitor, suppresses leukemia (MV4-11, NB4) and impedes prostate cancer (LNCaP) cell growth.</p>Fórmula:C22H20N2OForma y color:SolidPeso molecular:328.41Porphobilinogen
CAS:<p>Porphobilinogen act as a phytotoxin, a metabotoxin, and a neurotoxin.</p>Fórmula:C10H14N2O4Pureza:98%Forma y color:SolidPeso molecular:226.23MAO-B-IN-10
<p>MAO-B-IN-10: Potent, selective MAO-B inhibitor; crosses blood-brain barrier; IC50 5.3 μM; reduces Aβ aggregation 58.2%, disaggregates 43.3%.</p>Fórmula:C23H26N2O4Forma y color:SolidPeso molecular:394.46BI-685509
CAS:<p>BI-685509: potent, oral sGC activator, boosts cGMP, enhances NO pathways, for CKD/DKD research.</p>Fórmula:C34H38N4O5Forma y color:SolidPeso molecular:582.69Tylophorinidine
CAS:<p>Tylophorinidine is an antifungal agent that has shown to inhibit cell growth.</p>Fórmula:C22H23NO4Forma y color:SolidPeso molecular:365.42SBI-581
<p>SBI-581: oral, potent TAO3 inhibitor, IC50=42nM, alters TKS5α at RAB11+ vesicles, blocks invadopodia, good mouse pharmacokinetics, anti-tumor.</p>Fórmula:C24H21N3O2Forma y color:SolidPeso molecular:383.44Ac-ATS010-KE
CAS:<p>Ac-ATS010-KE is a novel Selective, irreversible, and Rapid Cell-Permeable Inhibitor of Human Caspase-3.</p>Fórmula:C43H41F5N6O12SForma y color:SolidPeso molecular:960.88Lorajmine
CAS:Lorajmine, a monochloroacetyl derivative of ajmaline, is a class Ia antiarrhythmic agent that is rapidly hydrolyzed to ajmaline by plasma and tissue esterases.Fórmula:C22H27ClN2O3Pureza:98%Forma y color:SolidPeso molecular:402.91NLRP3-IN-4
<p>NLRP3-IN-4 is an effective, oral NLRP3 inflammasome inhibitor with potent anti-inflammatory effects on colitis.</p>Fórmula:C22H22N2O5Forma y color:SolidPeso molecular:394.42SF0166
CAS:<p>SF0166: potent αvβ3 antagonist, IC50: 0.6 nM. Blocks cell adhesion, IC50: 7.6 pM-76 nM. Reduces neovascularization in mice.</p>Fórmula:C23H27F2N5O4Forma y color:SolidPeso molecular:475.49OP-5244
CAS:<p>OP-5244 has comparable potency to bisphosphonic acid series and targets CD73.</p>Fórmula:C19H29ClN5O9PPureza:98%Forma y color:SolidPeso molecular:537.89Antifungal agent 39
CAS:<p>Antifungal agent 39 (Compound 9h) is a broad-spectrum antifungal agent.</p>Fórmula:C23H22ClN3O5Forma y color:SolidPeso molecular:455.89BMS-961955
CAS:<p>BMS-961955 is an allosteric inhibitor of the hepatitis C virus NS5B polymerase.</p>Fórmula:C37H43FN4O4SForma y color:SolidPeso molecular:658.83Plagiochilin A
CAS:<p>Plagiochilin A Inhibits Cytokinetic Abscission and Induces Cell Death</p>Fórmula:C15H14O7Forma y color:SolidPeso molecular:306.27NNTA
CAS:<p>NNTA is a highly selective and potent activator of μ/κ-opioid heteromers.</p>Fórmula:C31H32N2O4Forma y color:SolidPeso molecular:496.60SHR0687
CAS:<p>SHR0687: potent KOR agonist, selective, favorable PK, effective in rat pain model, minimal BBB penetration, less CNS side effects.</p>Fórmula:C39H60N8O5Forma y color:SolidPeso molecular:720.94Human enteropeptidase-IN-2
<p>Human enteropeptidase-IN-2 is a potent inhibitor of enteropeptidase (enteropeptidase) and can be used in anti-obesity studies.</p>Fórmula:C20H19F3N4O7Forma y color:SolidPeso molecular:484.38FAK-IN-2
<p>FAK-IN-2: potent oral FAK inhibitor, IC50 35 nM, reduces tumor growth, migration, and induces cell death.</p>Fórmula:C28H31ClN8O3Forma y color:SolidPeso molecular:563.05Tovinontrine
CAS:<p>Tovinontrine (IMR-687) (IMR-687) is a potent and selective inhibitor of phosphodiesterase-9 (PDE9), designed to target sickle cell disease treatment.</p>Fórmula:C21H26N6O2Pureza:98.14%Forma y color:SolidPeso molecular:394.47FAPI-74
CAS:<p>FAPI-74 is a PET (positron emission tomography) tracer involved in early FAPI-PET imaging.FAPI-74 can be used to study cancer tumors and degenerative diseases.</p>Fórmula:C36H49N9O8Forma y color:SolidPeso molecular:735.83trans-RdRP-IN-5
<p>Trans-RdRP-IN-5 is a potent inhibitor of the influenza virus RNA-dependent RNA polymerase (RdRP), with applications in influenza virus research.</p>Fórmula:C23H21N3O5Forma y color:SolidPeso molecular:419.43CXCR2 antagonist 4
<p>CXCR2 antagonist 4 inhibits CXCR2 (IC50: 0.13 μM) and CXCL8-induced calcium rise (IC50: 27 μM), promising for cancer research.</p>Fórmula:C15H14F2N4OS2Forma y color:SolidPeso molecular:368.42Chitinase-IN-5
<p>Chitinase-IN-5 (8i) blocks OfChi-h (IC50: 0.051 μM), has insecticidal qualities, useful for eco-friendly pest control.</p>Fórmula:C20H21ClFN7Forma y color:SolidPeso molecular:413.88Top/HDAC-IN-1
<p>Top/HDAC-IN-1: Dual Top/HDAC inhibitor, potent against HDAC1-3,6,8 and HCT116 cells; blocks G2 phase, induces apoptosis.</p>Fórmula:C29H27N5O4Forma y color:SolidPeso molecular:509.56ZM514
<p>ZM514 inhibits CD73 (hCD73 IC50: 1.39 μM, mCD73 IC50: 14.65 μM) with low cytotoxicity, suitable for cancer research.</p>Fórmula:C36H57NO4Forma y color:SolidPeso molecular:567.84Antileishmanial agent-5
<p>Antileishmanial agent-4, a ribonucleoside analogue, targets L.infantum and T.cruzi with EC50s of 0.68 μM and 0.83 μM.</p>Fórmula:C17H17ClN4O4Forma y color:SolidPeso molecular:376.79Cav 3.2 inhibitor 3
<p>Cav 3.2 inhibitor 3 is a potent inhibitor of the Cav3.2 T-type Ca2+channel (IC50: 0.1534 μM) and has a low binding affinity for D2 receptors.</p>Fórmula:C32H37N3O2Forma y color:SolidPeso molecular:495.66E-3030 free acid
CAS:<p>E-3030 free acid, a PPAR agonist, lowers blood glucose, triglycerides, and insulin; boosts adiponectin; reduces apo C-III; and raises lipoprotein lipase.</p>Fórmula:C22H23ClFNO5Pureza:98%Forma y color:SolidPeso molecular:435.87LP-284
CAS:<p>LP-284 is a DNA alkylating agent effective against solid tumors and hematologic cancers like MCL.</p>Fórmula:C16H20N2O4Forma y color:SolidPeso molecular:304.34Aplaviroc
CAS:<p>Aplaviroc (AK 602), a SDP derivative, is a CCR5 antagonist. With IC50s of 0.1-0.4 nM for HIV-1Ba-L, HIV-1JRFL and HIV-1MOKW.</p>Fórmula:C33H43N3O6Pureza:97.98% - 98.26%Forma y color:SolidPeso molecular:577.7114α-Demethylase/DNA Gyrase-IN-1
14α-Demethylase/DNA Gyrase-IN-1 (Compound 7c) is a potent inhibitor of 14α-Demethylase/DNA Gyrase with antibacterial activity.Fórmula:C26H22N4O4Forma y color:SolidPeso molecular:454.48
![[D-Leu-4]-OB3](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTM%2Fthumb-webp%2FT72906.webp&w=3840&q=75)
